homocysteine has been researched along with D-fructopyranose in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritter, K | 1 |
| Fochem, K; Michalica, W; Picha, E | 1 |
| Bernhard, W; Fuchs, D; Ledochowski, M | 1 |
| EGER, W | 1 |
| TRUTSCHEL, W | 1 |
| LEUKERT, G; ZICHA, L | 1 |
| COFFEY, VP | 1 |
| FREITAS, PA | 1 |
| Oron-Herman, M; Rosenthal, T; Sela, BA | 1 |
| Kim, DW; Kim, JH; Lee, SY; Shon, YM | 1 |
| Bircan, FS; Kantar, Ş; Paşaoğlu, ÖT; Türközkan, N | 1 |
| Chopra, K; Dharavath, RN; Sachdeva, AK | 1 |
12 other study(ies) available for homocysteine and D-fructopyranose
| Article | Year |
|---|---|
[Studies on the radioprotective effect of sulfhydryl-compounds N-acetyl-homocysteine-thiolactone and cystein in combination with fructose].
Topics: Animals; Cysteine; Drug Synergism; Fructose; Homocysteine; Lactones; Male; Mice; Radiation Injuries, Experimental; Radiation Protection; Radiation-Protective Agents; Sulfhydryl Compounds | 1971 |
[On the effect sulfhydryl compounds as radiation protective agents in combination with fructose].
Topics: Animals; Cysteine; Fructose; Homocysteine; Mice; Radiation Injuries, Experimental; Radiation-Protective Agents; Sarcoma, Yoshida; Sulfhydryl Compounds | 1967 |
Homocysteine and heart disease in Indian Asians.
Topics: Coronary Disease; Folic Acid; Folic Acid Deficiency; Fructose; Homocysteine; Humans; Hyperhomocysteinemia; India; Malabsorption Syndromes; United Kingdom; Vitamin B 12 | 2000 |
[Cysteine, homocysteine, cystathionine & cysteinamine as necrotropic liver protective substances, combined with glucose & fructose].
Topics: Catabolite Repression; Cystathionine; Cysteamine; Cysteine; Fructose; Glucose; Homocysteine; Humans; Liver; Mercaptoethylamines | 1957 |
[Homocysteine-thiolactone, cysteine and fructose therapy of acute and chronic hepatitis].
Topics: Cysteine; Fructose; Hepatitis; Hepatitis A; Hepatitis, Chronic; Homocysteine; Humans; Propionates | 1957 |
[The influence of 1-cysteine, d, 1-homocysteine thiolactone and d-fructose on the 17-ketosteroid fractions in the urine of patients with liver diseases].
Topics: 17-Ketosteroids; Body Fluids; Cysteine; Fructose; Homocysteine; Humans; Liver Diseases; Organic Chemicals | 1959 |
MENTAL RETARDATION AND THE INBORN ERRORS OF METABOLISM.
Topics: Alkaptonuria; Amino Acid Metabolism, Inborn Errors; Arginine; Citrulline; Fructose; Galactosemias; Histidine; Homocysteine; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Intellectual Disability; Maple Syrup Urine Disease; Metabolic Diseases; Phenylketonurias; Renal Aminoacidurias; Vitamin B 6 Deficiency | 1964 |
[THERAPY OF ACUTE AND CHRONIC HEPATIC DISEASES WITH THE DRUG ASSOCIATION, HOMOCYSTEINE-THIOLACTONE, CYSTEINE AND FRUCTOSE].
Topics: Chemical and Drug Induced Liver Injury; Cysteine; Fructose; Hepatitis; Hepatitis A; Hepatitis B virus; Homocysteine; Humans; Lactones; Liver Cirrhosis; Liver Diseases | 1963 |
Hyperhomocysteinemia as a component of syndrome X.
Topics: Animals; Blood Pressure; Cholesterol; Diet; Fructose; Homocysteine; Hyperhomocysteinemia; Insulin; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Triglycerides | 2003 |
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Biomarkers; Carbamazepine; Cholesterol, LDL; Epilepsy; Female; Fructose; Homocysteine; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam; Prospective Studies; Risk Factors; Topiramate | 2013 |
Beneficial effects of melatonin on serum nitric oxide, homocysteine, and ADMA levels in fructose-fed rats.
Topics: Animals; Arginine; Biomarkers; Fructose; Homocysteine; Male; Melatonin; Metabolic Syndrome; Nitric Oxide; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |
Time-response studies on development of cognitive deficits in an experimental model of insulin resistance.
Topics: Animals; Biomarkers; Blood Glucose; Cognitive Dysfunction; Cytokines; Disease Models, Animal; Fructose; Homocysteine; Insulin; Insulin Resistance; Male; Oxidative Stress; Rats; Rats, Wistar; Time Factors | 2019 |